General News
Meropi Kyriacou Honored as TNH Educator of the Year
NEW YORK – Meropi Kyriacou, the new Principal of The Cathedral School in Manhattan, was honored as The National Herald’s Educator of the Year.
WASHINGTON, DC – The United States has announced that it will work with the drug company Regeneron to develop an effective treatment for the new Chinese coronavirus, using drugs that have been tested to fight the Ebola virus.
Many different therapies are currently being tested for the new coronavirus (2019-nCoV), three of which are at an advanced stage: a drug administered to HIV carriers (Kaletra), a combination of drugs used for the coronavirus MERS (antivirals and immunotherapy) and a U.S. company Gilead antivirus that had been previously tested for Ebola virus.
The partnership between the U.S. government and Regeneron concerns a treatment based on monoclonal antibodies. “A public-private partnership, like the one we have with Regeneron since 2014, allows us to respond quickly to new global health threats,” said Rick Bright, a U.S. health official.
Monoclonal antibodies are copies of one type of antibody prepared in the laboratory. They are a kind of immunotherapy. They attach to certain proteins of the virus and neutralize its ability to invade human cells.
Regeneron has created the cocktail REGN-EB3, which consists of three monoclonal antibodies and last year significantly improved the survival rate of patients infected with Ebola virus in the Congo. The company has also developed a treatment for Middle Eastern Respiratory Syndrome (MERS).
“The convincing results of our experimental treatment for Ebola last year showed Regeneron’s ability to respond quickly to new outbreaks,” explained Greek-American Dr. George Yancopoulos, Regeneron’s President and chief scientific officer.
The cure for the new coronavirus may eventually include many types of medication.
The coronavirus epidemic is likely to have an impact on U.S. supply chains, but the consequences are unlikely to be disastrous, White House financial adviser Larry Cadlow said in an interview with Fox Business, ANA-MPA reported.
“It’s not a disaster,” Cadlow said, adding that “we’ve had it in the past and I just think the impact is minimal,” ANA-MPA reported.
The American-born Dr. Yancopoulos, one of the nation’s leading scientists and head of one of the largest pharmaceutical companies listed on the New York Stock Exchange, grew up in Woodside, Queens. He was the valedictorian of both the Bronx High School of Science and Columbia University, and received his MD and PhD degrees in 1987 from Columbia University’s College of Physicians & Surgeons. Yancopoulos worked in the field of molecular immunology at Columbia University with Dr. Fred Alt, and received the Lucille P. Markey Scholar Award for his efforts. In 1989, he left his academic career and became the founding scientist for Regeneron with Leonard Schleifer. Among his honors, Yancopoulos was awarded Columbia University’s Stevens Triennial Prize for Research and its University Medal of Excellence for Distinguished Achievement. In 2004, he was elected to the National Academy of Sciences and the American Academy of Arts and Sciences.
NEW YORK – Meropi Kyriacou, the new Principal of The Cathedral School in Manhattan, was honored as The National Herald’s Educator of the Year.
DEIR AL-BALAH, Gaza (AP) — An international team of doctors visiting a hospital in central Gaza was prepared for the worst.
ATHENS - The tragedy of the Tempi train collision is a much greater issue than an opportunity for parties to table a motion of censure against the government, but the opposition parties used it anyway "to turn society's pain into a tool to strike at the government and me personally," Prime Minister Kyriakos Mitsotakis said on Thursday night in parliament.
ATHENS - PASOK-KINAL leader Nikos Androulakis, speaking at the Hellenic Parliament on Thursday, emphasized that there is "an established belief among the Greek people" that the government "operates as a well-oiled machine of corruption, cover-up, and propaganda.
ATHENS — Greece’s center-right government survived a motion of no-confidence late Thursday that was brought by opposition parties over its handling of the country’s deadliest rail disaster a year ago.
ASTORIA – Greek Minister of the Interior Niki Kerameus offered an informative presentation on postal voting in the upcoming European Union elections for Greek citizens in a well-attended event held at the St.